To estimate prevalence and number of people visually impaired or blind due to cataract.
METHODS
Medline, Embase, and the WHO (World Health Organization) library information system were used to search for articles published between 1980 and 2012. Search terms included concepts to describe ''blindness,'' ''visual impairment,'' ''population,'' ''eye,'' ''survey,'' and a list of ocular disorders. Of 14,908 relevant manuscripts primarily identified, 243 population-based studies remained after application of rigorous selection criteria and review by an expert panel. 3, 10 Criteria for inclusion included (1) random-sample cross-sectional surveys of representative populations of any age of a country or area of a country; studies using hospital or clinic case series, blindness registries, and interview studies with self-reported vision status were not included; (2) definitions of visual impairment or blindness were clearly stated, using thresholds of visual acuity, in the better eye that matched or could be later modeled to match to the following definitions: mild vision impairment (<6/12 to 6/18), moderate vision impairment (<6/ 18 to 6/60), severe vision impairment (<6/60 to 3/60), or blindness (<3/60); (3) best-corrected and/or presenting visual acuity was recorded; and (4) procedures used for measurement of visual acuity needed to be clearly stated.
As recently described in detail, additional unpublished data sources through personal communication with researchers identified in the literature search were found. 3, 10 Additional data sources were identified through personal communications with researchers, including enquiries about additional data from authors of published studies. These data were used only if information about the study population and measurement methods were available. We applied the same inclusion criteria to these data sources as were used in the published articles identified in the systematic review. Additionally, published and unpublished results from rapid assessment survey methodologies that follow consistent protocols, such as the Rapid Assessment of Avoidable Blindness and the Rapid Assessment of Cataract Surgical Services, augmented the population-based data. 11 Population-based studies that reported prevalence disaggregated by cause (128 studies) provided the basic data to calculate the proportion of blindness and moderate to severe vision impairment (MSVI) that were due to cataract, besides other causes, such as macular degeneration, glaucoma, diabetic retinopathy, trachoma, or uncorrected refractive errors. A full list of data sources used for each cause has been published recently. 10 For 18 of 21 Global Burden of Disease (GBD) study regions, at least two studies were identified. However there were no studies with cause-specific data identified in two of the GBD study regions (Central Africa, Eastern Europe) and only one study was identified for Central Europe. There was no identified study for 126 of the 191 countries defined by the WHO and United Nations. Blindness was defined as presenting visual acuity less than 3/60 in the better eye, and MSVI was defined as visual acuity in the better eye lower than 6/18 but at least 3/60 at presentation.
We estimated trends in causes of vision impairment, including analysis of uncertainties, by age, sex, and geographical region. For the latter, we used the 21 regions defined in the GBD study. 12 The statistical analysis was performed in three steps. The first step included the data identification and access; the second step consisted of the estimation of fractions for each cause, stratified by the severity of vision impairment, sex, age, and region; and the third step included the application of cause fractions to the prevalence of all-cause presenting vision impairment, which was assessed previously. 10 For the statistical analysis, the DisMod-MR model from the GBD was used to calculate the fraction of vision impairment due to macular degeneration and the other causes mentioned above. It has been described in detail recently. 3, 10 Briefly, DisMod-MR is a negative binomial regression model including the following elements: covariates that predict variation in the true proportion of vision impairment from each disease (e.g., year); fixed effects that adjust for definitional differences (e.g., whether the causes of presenting versus best-corrected vision impairment were reported); a hierarchical model structure that fits random intercepts in individual countries derived from the data observed in the country, in its region, and in other regions based on the availability and consistency of country-and region-specific data; age-specific fixed effects allowing for a nonlinear age pattern; and a fixed effect for data on males. For the assessment of the fractions of blindness and visual impairment due to cataract, we fit one DisMod-MR model using three covariates: an indicator variable describing whether the data were for blindness or for MSVI, an indicator variable describing whether the data were based on presenting visual acuity or best-corrected visual acuity measurements, and a country-level covariate reflecting health systems access. We made two sets of the prediction for cataract: one for bestcorrected blindness and one for best-corrected MSVI. For the presentation of the data, we present age-standardized prevalence in the 50 years and older population using the WHO reference population 13 and crude prevalence for all ages. The numbers of people with vision impairment and blindness due to cataract were also calculated, which reflects each region's population size and age structure. Pearson's v 2 test was used to assess associations. A P value of 0.05 was considered statistically significant.
RESULTS
Of overall 32.4 million people blind and 191 million people vision impaired in 2010, 10 3 This represents an 11.4% decrease in the number of people affected by blindness due to cataract (À1.4 million, UI: À1.3 to À1.9) and a 20.2% decrease in the number of people moderately or severely visually impaired (À8.9 million, UI: 6.0-8.9) over a 20-year period (Tables 1, 2). If only people with an age of 50 years or older were included, the number of people blind due to cataract decreased from 11.1 million (UI: 9.7-12.8) in 1990 to 9.8 million (UI: 8. The age-standardized global prevalence of cataract-related blindness and MSVI was reduced by 46% and 50%, respectively, and the worldwide crude prevalence of cataract-related blindness and MSVI was reduced by 32% and 39%, respectively ( Table 3) .
A decrease of percentage of global blindness and of global MSVI caused by cataract from 1990 to 2010 took place in almost world regions, except in East Sub-Saharan Africa (35.4% [31.7-39.8] in 1990 vs. 36.7% [31.9-41.5] in 2010) ( Tables 1,  2 ).
The decline in age-standardized prevalence of blindness or MVSI due to cataract was greatest in East Asia, Tropical Latin America, and Western Europe, in all of which prevalence fell by more than half. The region with the least decline was East Sub-Saharan Africa ( Table 3) . A reduction in crude and age-standardized prevalence of more than 50% was observed in two regions for cataract blindness (Central Asia and Central Sub-Saharan Africa) and in five regions for cataract-related MSVI (East and Central Asia, Western Europe, Western and Central Africa) ( 
DISCUSSION
Results of our study show that despite the reduction in absolute numbers, crude and age-standardized prevalences, cataract remains the leading cause of blindness worldwide and in 16 world regions. In 2010, one of three blind people was blind due to cataract, and one of six visually impaired people were visually impaired due to cataract. 
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In 2010, the age-standardized prevalence of blindness and MSVI caused by cataract in people aged 50 years and older were reduced by half from 1.3% to 0.7% and from 4.4% to 2.2%, respectively, compared with 1990. In a similar manner, the agestandardized prevalence of trachoma and uncorrected refractive error showed the greatest declines worldwide between 1990 and 2010. For glaucoma, macular degeneration, and diabetic retinopathy, prevalence declined less (for blindness), or increased slightly (for MSVI). 3 It has been recently shown that the worldwide agestandardized prevalence for blindness and for MSVI declined substantially from 1990 to 2010, and of this overall decline in vision impairment, approximately half was a result of decline in vision impairment caused by cataract. 3 This decline may also indicate a shift in the relative importance of the various diseases as causes for blindness and visual impairment, with a decline for causes of avoidable blindness, which are relatively easily, safely, and cost-efficiently treatable diseases, 14 and diseases such as glaucoma, macular degeneration, and diabetic retinopathy, the management of which needs efforts and takes considerably more time with a markedly lower rate of success. This decline may also reflect the effect of the Vision 2020 the Right to Sight initiative of WHO and the International Agency for the Prevention of Blindness. 15 This global partnership for the elimination of avoidable blindness that involves a collaboration of international nongovernmental organizations, professional associations, and eye-care institutions has laid great emphasis on increasing the numbers of people receiving cataract surgery, particularly in low-and middle-income countries. During the period under consideration, the total number of cataract surgeries more than tripled in the world and the cataract surgical rate (i.e., the number of surgeries per million population per year) increased in all regions, especially in Asia, 16 with improvement of surgical techniques, and a lower rate of complications. 17, 18 However, despite the decline in prevalence of blindness and MSVI, cataract remains the first cause of blindness in 2010 followed by uncorrected refractive error and macular degeneration, and the second cause of MSVI after uncorrected refractive error. 3 This may be the result of rapid aging of populations, with a growth rate of ophthalmologists lower than the growth rate of the population older than 60 years, 17 in addition to the barriers to uptake of cataract surgery that still exist in most countries. In fact, our data show that globally, the age-standardized prevalence declined more dramatically than the crude prevalence for both blindness (À46% vs. À32%) and MSVI (À50% vs. À39%), which reflects the effect of the demographic transition. The surgical services are struggling to cope with the aging of the population; this is particularly marked in the Asia Pacific, high-income region, where the crude prevalence of cataract blindness declined by 18% only while the age-standardized prevalence dropped by 59%. Conversely, in Western Sub-Saharan Africa, crude and agestandardized prevalences declined both by 39%.
Other barriers include surgical cost, lack of family support, and failure to understand the need for surgery and other social, infrastructural, and geographic factors, such as disparity in the distribution of ophthalmologists leading to unsatisfactory coverage across some regions and difficulties in accessing eye-care centers with patients having to travel too far and not having anyone to accompany them. 17, [19] [20] [21] [22] [23] Quality of cataract surgery also remains a concern, with poor outcomes reaching 40% in some places. 24 In fact, many ophthalmologists do not perform surgery or may be inadequately trained. 17, 25, 26 Cataract, therefore, continues to be a challenge to tackle with the need to plan a comprehensive strategy addressing issues related to availability, affordability, accessibility, and acceptability of eye-care services, and improving outcome of cataract surgery in low-and middle-income countries. 27 In addition, reduction of cataract-related blindness and visual impairment will have a positive impact on long-term survival. In fact, recent studies show that correcting related visual impairment by cataract surgery was associated with improvements in quality of life and a lower mortality risk compared with that of older persons whose moderate to severe levels of visual impairment persisted, independent of other known mortality risk factors. [28] [29] [30] Globally, women as compared with men had a larger percentage of blindness and MSVI caused by cataract. Worldwide, 35.5% of blindness among women was caused by cataract versus 30.1% of blindness among men; for MSVI, the figures were 20.2% vs. 15.9%, respectively. A recent metaanalysis revealed that sex inequity in use of cataract surgical services persists in the low-and middle-income countries, and that men were 1.71 times (95% confidence interval [CI]: 1.48-1.97) more likely to have cataract surgery than women. 31 It is estimated in that study that blindness and severe visual impairment from cataract could be reduced by approximately 11% in the low-and middle-income countries if women were to receive cataract surgery at the same rate as men. 31 Similarly, a previous study found that the cataract surgical coverage rate was 1.2 to 1.7 times higher for males than for females and that the odds ratio of having surgery, compared with males, was 0.67 (95% CI: 0.60-0.74). Estimates in that study suggest that the prevalence of cataract blindness in developing countries would be reduced by a median of 12.5% if women received surgery at the same rates as men. 32 In contrast, a survey from Latin American countries in which cataract surgical cover was assessed; sex does not appear to be a significant factor in receiving cataract surgery. 33 Additional focus is needed to bring cataract surgical services to women mainly in low-and middleincome countries.
Literature reviews published by WHO and the WHO Prevention of Blindness and Deafness program have previously been used to make worldwide estimates of numbers of people blind or with vision impairment. The latest of these studies included literature published in the period from 2000 to 2010. 2 That analysis was limited to three age groups, with no breakdown by sex, or estimates for the six WHO epidemiological subregions within a more limited time frame. In contrast, the present study achieved a greater degree of granularity in its analysis, analyzed in 5-year age brackets, allowed the disaggregation by sex, time series estimates for the period 1990 to 2010, and a geographic breakdown for 190 countries in the 21 geographic regions identified by the GBD. These factors led to more detailed estimations of prevalence of vision impairment of all causes including cataracts.
Our study had some limitations. First, as also pointed out in our previous study on the global prevalence of vision loss, 3,10 a major limitation was that many country-years remained without data, or only had subnational data. Only a few national studies reporting vision impairment for all ages and all causes were available. Second, some data sources did not report prevalence by age. To use these data, we imputed age-specific cause fractions, assuming that the age pattern of vision impaired in the study matched the modeled age pattern of vision impaired in the country in which the study was carried out. 10 Third, classification of cataract may not be uniform and may vary from one study to another. Fourth, in most surveys, protocol dictated that population-based studies will report one cause as the principal cause for an individual examined in that particular study, so as to arrive at the causal prevalence. When there were multiple disorders contributing equally to visual loss, only the ''most readily curable'' or the ''most easily preventable'' was recorded. 34 This approach has the potential to underestimate the impact of diabetic retinopathy, glaucoma, or other diseases when the patient presents with cataract, while underestimating the burden of cataract when patients also have an uncorrected refractive error. 35 Finally, some studies had a relatively small sample size. Therefore, the CIs of the cause-specific prevalence estimate were relatively large. Our methods, however, took into account sample size, so that studies with small sample sizes influenced the estimates less than studies with large sample sizes. The strengths of our study included the amount of population-based data accessed and used, analysis of trends in the causes of vision impairment, incorporation of nonlinear age trends and accounting for data that were not reported by age, and systematic quantitative analysis and reporting of uncertainty. The large network of ophthalmologic researchers involved in identification and evaluation of data sources ensured to access unpublished materials (unpublished data from 48 population-based studies, 4 from government reports, and 44 from Rapid Assessment of Cataract Surgical Services and Rapid Assessment of Avoidable Blindness surveys were assessed), to obtain additional unpublished data from study investigators who had published only summary data, to evaluate all major studies of vision impairment, and to include only studies that met inclusion criteria governing population representativeness and clarity of visual acuity procedures and definitions.
In conclusion, despite major improvements in terms of reduction of prevalence, cataract remains a major public health problem. Additional efforts in terms of advocacy, availability, affordability, and accessibility to high-volume and high-quality cataract surgery mainly in developing countries are mandatory to achieve the global target set by WHO target, which is a 25% reduction in the prevalence of avoidable visual impairment.
